Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem

NCT00319982 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG: Diltiazem
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]